ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
생명과학 BPO 시장의 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 10.1%로 4,329억 1,000만 달러로 성장할 전망입니다. 예측기간의 성장은 의약품 개발 지원 수요 증가, 실사용증거와 데이터 분석의 중시, 세계화와 확대 전략, 정밀의료의 중시 고조, 임상시험 관리의 아웃소싱 증가 등에 기인할 것으로 전망됩니다. 예측기간의 주요 동향으로는 AI와 고급 분석의 통합, 가상 테스트 및 원격 모니터링, 규정 준수 솔루션에 대한 주력, 정밀의료 및 맞춤의료, 블록체인 및 데이터 보안 솔루션 등이 있습니다.
향후 5년간의 예측 성장률 10.1%는 과거 예측에서 0.1% 소폭 감소한 수치입니다. 이러한 성장세 둔화는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 상승은 인도 및 필리핀에서 조달하는 임상 데이터 관리 및 약사 서비스의 외주비를 늘리고 운영 경비를 악화시키며 의약품 개발 일정을 지연시켜 미국의 생명공학기업에 부담을 줄 가능성이 높습니다. 또한 상호관세나 무역 마찰 및 제한의 격화에 의한 세계 경제 및 무역에 대한 악영향에 의해 그 영향은 보다 광범위하게 미칠 것으로 보입니다.
헬스케어 지출 증가는 미래의 생명과학 BPO 시장의 성장을 이끌 것으로 예측됩니다. 헬스케어 지출이란 헬스케어 관련 상품과 서비스에 대한 총 지출을 말하며, 치료, 투약, 입원, 진료, 의료기기, 건강보험, 기타 헬스케어 관련 비용 등 폭넓은 카테고리가 포함됩니다. 생명과학 BPO 솔루션은 환자에게 필수적인 의약품, 장비 및 서비스를 제공하는 헬스케어 회사를 지원합니다. 신흥국 시장에 대한 헬스케어 투자는 비용 최적화, 개발 속도 향상, 신규 치료 시장 개척 가속화, R&D 비용 절감 등의 능력을 더욱 향상시키고 있습니다. 예를 들어 2023년 12월 미국의 연방기구 Medicare & Medicaid Service Center는 미국 의료비가 2022년 4.1% 증가하여 4조 5,000억 달러에 이르렀으며 2021년 3.2% 증가보다 빠른 성장률이었다고 보고했습니다. 이러한 이유로 의료비 증가는 생명과학 BPO 시장의 성장을 뒷받침하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 생명과학 BPO : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 생명과학 BPO 시장 : 성장률 분석
세계의 생명과학 BPO 시장 실적 : 규모와 성장(2019-2024년)
세계의 생명과학 BPO 시장 예측 : 규모와 성장(2024-2029년, 2034F)
세계의 생명과학 BPO : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 생명과학 BPO 시장 : 서비스별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
의약품 아웃소싱
의료기기 아웃소싱
계약 판매 및 마케팅 아웃소싱
기타 서비스
세계의 생명과학 BPO 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
임상 검사 방법
환경 시험 방법
기타 용도
세계의 생명과학 BPO 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
병원 및 진료소
진단실험실
기타 최종 사용자
세계의 생명과학 BPO 시장 : 세분화 의약품 아웃소싱(유형별), 분석과 예측(2019-2024년, 2024-2029F, 2034F)
의약품 개발 서비스
임상시험 관리
규제 관련 서비스
의약품 안전성 감시
세계의 생명과학 BPO 시장 : 세분화 의료기기 아웃소싱(유형별), 분석과 예측(2019-2024년, 2024-2029F, 2034F)
제품 개발 서비스
규제 준수
품질 보증 및 테스트
공급망 관리
세계의 생명과학 BPO 시장 : 세분화 계약 판매 및 마케팅 아웃소싱(유형별), 분석과 예측(2019-2024년, 2024-2029F, 2034F)
영업 아웃소싱
마케팅 전략 개발
시장 접근 및 가격 전략
프로모션 활동
세계의 생명과학 BPO 시장 : 세분화 기타 서비스(유형별), 분석과 예측(2019-2024년, 2024-2029F, 2034F)
데이터 관리 및 분석
IT서비스
트레이닝 및 교육
컨설팅 서비스
제7장 지역별/국가별 분석
세계의 생명과학 BPO 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
세계의 생명과학 BPO 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
생명과학 BPO 시장 : 경쟁 구도
생명과학 BPO 시장 : 기업 프로파일
Accenture plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Atos SE : 개요, 제품 및 서비스, 전략 및 재무 분석
Catalent Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Covance Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Genpact Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
ICON plc
Infosys Ltd.
Lonza Group
PAREXEL International Corp.
IQVIA Holdings Inc.
International Business Machines Corp.
ProMab Biotechnologies Inc.
Cognizant Technology Solutions
Syneos Health Inc.
R1 RCM Inc.
Charles River Laboratories International Inc.
Sartorius AG
WuXi AppTec Co. Ltd.
Medpace Holdings Inc.
Pharmaceutical Product Development LLC
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
생명과학 BPO 시장(2029년) : 새로운 기회를 제공하는 국가
생명과학 BPO 시장(2029년) : 새로운 기회를 제공하는 부문
생명과학 BPO 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
Life sciences BPO (Business Process Outsourcing) involves outsourcing various business processes of life sciences companies to third-party experts. These specialized services support life sciences firms in areas such as data management, regulatory compliance, and customer support within the life sciences sector.
The primary types of services included in life sciences BPO are pharmaceutical outsourcing, medical device outsourcing, contract sales and marketing outsourcing, and others. Pharmaceutical outsourcing involves the delegation of specific tasks or functions related to drug development, manufacturing, and distribution processes to external service providers. These services find application in various areas, including clinical testing methods, environmental testing methods, and others. End-users of these services include hospitals and clinics, diagnostic laboratories, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The life sciences BPO market research report is one of a series of new reports from The Business Research Company that provides life sciences BPO market statistics, including life sciences BPO industry global market size, regional shares, competitors with a life sciences BPO market share, detailed life sciences BPO market segments, market trends and opportunities, and any further data you may need to thrive in the life sciences BPO industry. This life sciences BPO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The life sciences bpo market size has grown rapidly in recent years. It will grow from $266.44 billion in 2024 to $294.54 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to focus on patient-centric healthcare solutions, increasing data management challenges, market competition and time-to-market pressure, globalization and expansion, complexity in clinical trials.
The life sciences bpo market size is expected to see rapid growth in the next few years. It will grow to $432.91 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for drug development support, focus on real-world evidence and data analytics, globalization and expansion strategies, increased emphasis on precision medicine, rise in outsourcing clinical trial management. Major trends in the forecast period include ai and advanced analytics integration, virtual trials and remote monitoring, focus on regulatory compliance solutions, precision medicine and personalized healthcare, blockchain and data security solutions.
The forecast of 10.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. biotech firms by driving up the cost of outsourced clinical data management and regulatory services sourced from India and the Philippines, exacerbating operational expenses and delaying drug development timelines. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing healthcare expenditure is expected to drive the growth of the life sciences BPO market in the future. Healthcare expenditure refers to the total spending on healthcare-related goods and services, covering a wide range of categories such as medical treatments, medications, hospital stays, doctor visits, medical devices, health insurance, and other healthcare-related expenses. Life sciences BPO solutions support healthcare companies in delivering essential drugs, devices, and services to patients. The growing healthcare investments further enhance their ability to optimize costs, speed up development, accelerate the introduction of new treatments to the market, and lower research and development costs. For instance, in December 2023, the Centers for Medicare & Medicaid Services, a US-based federal agency, reported that U.S. healthcare spending increased by 4.1% in 2022, reaching $4.5 trillion, a faster growth rate than the 3.2% increase in 2021. Therefore, the rise in healthcare expenditure is fueling the growth of the life sciences BPO market.
Clinical trials support is expected to play a crucial role in propelling the growth of the life sciences BPO market going forward. Clinical trials support involves the services and activities that facilitate and manage clinical trials, which are research studies with human participants aimed at assessing the safety and effectiveness of new medical treatments, drugs, therapies, medical devices, or interventions. Professionals in clinical trials support help maintain the quality and integrity of clinical trial data, ensuring compliance with regulatory standards. This focus on data quality is vital for BPO providers managing clinical trial data, often a core service for life sciences companies. For example, in May 2023, Xtalks, a Canada-based digital health company, reported that there were 452,604 clinical trials registered globally as of May 17, 2023. Of these, 64,838 were actively recruiting participants. This represents a significant increase compared to more than 365,000 registered trials reported in early 2021. Therefore, clinical trials support is driving the growth of the life sciences BPO market.
Major companies in the life sciences BPO market are adopting a strategic partnership approach to develop innovative solutions. These partnerships allow life sciences BPO firms to combine resources and expertise, boosting research and development capabilities, expanding market reach, and accelerating commercialization, ultimately fostering innovation and growth in the industry. For example, in March 2024, Cognizant Technology Solutions Corp, a US-based company, formed a partnership with NVIDIA, a US-based software company. Through this collaboration, the two companies aim to accelerate drug discovery by leveraging NVIDIA's BioNeMo generative AI platform, which enables faster and more efficient analysis of complex datasets. The goal of this partnership is to enhance research capabilities and speed up the development of life-saving treatments.
In September 2022, Infosys Limited, an India-based IT company, acquired BASE life science for an undisclosed amount. This acquisition aims to enhance Infosys' expertise in the life sciences sector by incorporating BASE life science's consulting and technology capabilities. The goal is to drive innovation in clinical trials and drug development, ultimately improving health outcomes through advanced data and cloud solutions. BASE life science, a Denmark-based information technology consulting firm, specializes in providing technology solutions and consulting services to the life sciences industry, with a focus on areas such as data science, digital marketing, clinical trials, and regulatory compliance.
Major companies operating in the life sciences bpo market report are Accenture PLC, Atos SE, Catalent Inc., Covance Inc., Genpact Ltd., ICON PLC, Infosys Ltd., Lonza Group, PAREXEL International Corp., IQVIA Holdings Inc., International Business Machines Corp., ProMab Biotechnologies Inc., Cognizant Technology Solutions, Syneos Health Inc., R1 RCM Inc., Charles River Laboratories International Inc., Sartorius AG, WuXi AppTec Co. Ltd., Medpace Holdings Inc., Pharmaceutical Product Development LLC, Medidata Solutions, Health Decisions Inc., FAREVA Unterach GmbH, Bioclinica Inc., Navitas Life Sciences Private Limited, SGS SA, PRA Health Sciences Inc., Clinipace Worldwide, ClinTec International Ltd., Cromsource Ltd.
Asia-Pacific was the largest region in the life sciences BPO market in 2024. The regions covered in the life sciences bpo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the life sciences bpo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The life sciences BPO market includes revenues earned by entities by providing research and analytics, digital transformation, finance and accounting, and procurement. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Life Sciences BPO Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on life sciences bpo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for life sciences bpo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The life sciences bpo market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Services: Pharmaceutical Outsourcing; Medical Devices Outsourcing; Contract Sales And Marketing Outsourcing; Other Services
2) By Application: Clinical Testing Methods; Environmental Testing Methods; Other Applications
3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Pharmaceutical Outsourcing: Drug Development Services; Clinical Trials Management; Regulatory Affairs Services; Pharmacovigilance
2) By Medical Devices Outsourcing: Product Development Services; Regulatory Compliance; Quality Assurance And Testing; Supply Chain Management
3) By Contract Sales And Marketing Outsourcing: Sales Force Outsourcing; Marketing Strategy Development; Market Access And Pricing Strategies; Promotional Activities
4) By Other Services: Data Management And Analytics; IT Services; Training And Education; Consulting Services
Companies Mentioned: Accenture plc; Atos SE; Catalent Inc.; Covance Inc.; Genpact Ltd.; ICON plc; Infosys Ltd.; Lonza Group; PAREXEL International Corp.; IQVIA Holdings Inc.; International Business Machines Corp.; ProMab Biotechnologies Inc.; Cognizant Technology Solutions; Syneos Health Inc.; R1 RCM Inc.; Charles River Laboratories International Inc.; Sartorius AG; WuXi AppTec Co. Ltd.; Medpace Holdings Inc.; Pharmaceutical Product Development LLC; Medidata Solutions; Health Decisions Inc.; FAREVA Unterach GmbH; Bioclinica Inc.; Navitas Life Sciences Private Limited; SGS SA; PRA Health Sciences Inc.; Clinipace Worldwide; ClinTec International Ltd.; Cromsource Ltd.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Life Sciences BPO Market Characteristics
3. Life Sciences BPO Market Trends And Strategies
4. Life Sciences BPO Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Life Sciences BPO Growth Analysis And Strategic Analysis Framework
5.1. Global Life Sciences BPO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Life Sciences BPO Market Growth Rate Analysis
5.4. Global Life Sciences BPO Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Life Sciences BPO Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Life Sciences BPO Total Addressable Market (TAM)
6. Life Sciences BPO Market Segmentation
6.1. Global Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Outsourcing
Medical devices outsourcing
Contract sales and marketing outsourcing
Other Services
6.2. Global Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Testing Methods
Environmental Testing Methods
Other Applications
6.3. Global Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Laboratories
Other End Users
6.4. Global Life Sciences BPO Market, Sub-Segmentation Of Pharmaceutical Outsourcing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Development Services
Clinical Trials Management
Regulatory Affairs Services
Pharmacovigilance
6.5. Global Life Sciences BPO Market, Sub-Segmentation Of Medical Devices Outsourcing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Product Development Services
Regulatory Compliance
Quality Assurance And Testing
Supply Chain Management
6.6. Global Life Sciences BPO Market, Sub-Segmentation Of Contract Sales And Marketing Outsourcing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sales Force Outsourcing
Marketing Strategy Development
Market Access And Pricing Strategies
Promotional Activities
6.7. Global Life Sciences BPO Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Management And Analytics
IT Services
Training And Education
Consulting Services
7. Life Sciences BPO Market Regional And Country Analysis
7.1. Global Life Sciences BPO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Life Sciences BPO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Life Sciences BPO Market
8.1. Asia-Pacific Life Sciences BPO Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Life Sciences BPO Market
9.1. China Life Sciences BPO Market Overview
9.2. China Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Life Sciences BPO Market
10.1. India Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Life Sciences BPO Market
11.1. Japan Life Sciences BPO Market Overview
11.2. Japan Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Life Sciences BPO Market
12.1. Australia Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Life Sciences BPO Market
13.1. Indonesia Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Life Sciences BPO Market
14.1. South Korea Life Sciences BPO Market Overview
14.2. South Korea Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Life Sciences BPO Market
15.1. Western Europe Life Sciences BPO Market Overview
15.2. Western Europe Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Life Sciences BPO Market
16.1. UK Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Life Sciences BPO Market
17.1. Germany Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Life Sciences BPO Market
18.1. France Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Life Sciences BPO Market
19.1. Italy Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Life Sciences BPO Market
20.1. Spain Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Life Sciences BPO Market
21.1. Eastern Europe Life Sciences BPO Market Overview
21.2. Eastern Europe Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Life Sciences BPO Market
22.1. Russia Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Life Sciences BPO Market
23.1. North America Life Sciences BPO Market Overview
23.2. North America Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Life Sciences BPO Market
24.1. USA Life Sciences BPO Market Overview
24.2. USA Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Life Sciences BPO Market
25.1. Canada Life Sciences BPO Market Overview
25.2. Canada Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Life Sciences BPO Market
26.1. South America Life Sciences BPO Market Overview
26.2. South America Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Life Sciences BPO Market
27.1. Brazil Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Life Sciences BPO Market
28.1. Middle East Life Sciences BPO Market Overview
28.2. Middle East Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Life Sciences BPO Market
29.1. Africa Life Sciences BPO Market Overview
29.2. Africa Life Sciences BPO Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Life Sciences BPO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Life Sciences BPO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Life Sciences BPO Market Competitive Landscape And Company Profiles
30.1. Life Sciences BPO Market Competitive Landscape
30.2. Life Sciences BPO Market Company Profiles
30.2.1. Accenture plc Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Atos SE Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Covance Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Genpact Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Life Sciences BPO Market Other Major And Innovative Companies
31.1. ICON plc
31.2. Infosys Ltd.
31.3. Lonza Group
31.4. PAREXEL International Corp.
31.5. IQVIA Holdings Inc.
31.6. International Business Machines Corp.
31.7. ProMab Biotechnologies Inc.
31.8. Cognizant Technology Solutions
31.9. Syneos Health Inc.
31.10. R1 RCM Inc.
31.11. Charles River Laboratories International Inc.
31.12. Sartorius AG
31.13. WuXi AppTec Co. Ltd.
31.14. Medpace Holdings Inc.
31.15. Pharmaceutical Product Development LLC
32. Global Life Sciences BPO Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Life Sciences BPO Market
34. Recent Developments In The Life Sciences BPO Market
35. Life Sciences BPO Market High Potential Countries, Segments and Strategies
35.1 Life Sciences BPO Market In 2029 - Countries Offering Most New Opportunities
35.2 Life Sciences BPO Market In 2029 - Segments Offering Most New Opportunities
35.3 Life Sciences BPO Market In 2029 - Growth Strategies
